Driehaus Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,598
| Closed | -$1.1M | – | 620 |
|
|
2017
Q2 | $1.1M | Buy |
11,598
+1,295
| +13% | +$122K | 0.04% | 337 |
|
|
2017
Q1 | $1.48M | Sell |
10,303
-1,803
| -15% | -$259K | 0.05% | 315 |
|
|
2016
Q4 | $1.53M | Buy |
12,106
+2,757
| +29% | +$349K | 0.05% | 298 |
|
|
2016
Q3 | $1.43M | Buy |
9,349
+56
| +0.6% | +$8.57K | 0.05% | 313 |
|
|
2016
Q2 | $1.07M | Sell |
9,293
-162
| -2% | -$18.6K | 0.04% | 336 |
|
|
2016
Q1 | $1.07M | Sell |
9,455
-388
| -4% | -$44K | 0.03% | 362 |
|
|
2015
Q4 | $1.86M | Buy |
9,843
+4,145
| +73% | +$781K | 0.06% | 307 |
|
|
2015
Q3 | $969K | Buy |
5,698
+545
| +11% | +$92.7K | 0.03% | 346 |
|
|
2015
Q2 | $3.26M | Buy |
5,153
+2,082
| +68% | +$1.32M | 0.11% | 230 |
|
|
2015
Q1 | $1.58M | Sell |
3,071
-43
| -1% | -$22.1K | 0.05% | 363 |
|
|
2014
Q4 | $1.67M | Buy |
+3,114
| New | +$1.67M | 0.07% | 339 |
|
|
2013
Q3 | – | Sell |
-1,385
| Closed | -$1.51M | – | 523 |
|
|
2013
Q2 | $1.51M | Buy |
+1,385
| New | +$1.51M | 0.07% | 292 |
|